Connection
James Aronson to Drug Evaluation, Preclinical
This is a "connection" page, showing publications James Aronson has written about Drug Evaluation, Preclinical.
|
|
Connection Strength |
|
|
|
|
|
0.025 |
|
|
|
-
Liu L, Aronson J, Huang S, Lu Y, Czernik P, Rahman S, Kolli V, Suva LJ, Lecka-Czernik B. Rosiglitazone inhibits bone regeneration and causes significant accumulation of fat at sites of new bone formation. Calcif Tissue Int. 2012 Aug; 91(2):139-48.
Score: 0.025